data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Tenax Therapeutics
(NASDAQ:TENX)
$0.3182
0.0182[6.07%]
At close: Jul 1
$0.3182
00
After Hours: 7:27PM EDT
Day High/Low0.29 - 0.33
52 Week High/Low0.23 - 2.19
Open / Close0.32 / 0.32
Float / Outstanding23.5M / 25.2M
Vol / Avg.245.9K / 129.6K
Mkt Cap8M
P/E-
50d Avg. Price0.59
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float23.5M

Tenax Therapeutics (NASDAQ:TENX), Quotes and News Summary

Tenax Therapeutics (NASDAQ: TENX)

Day High/Low0.29 - 0.33
52 Week High/Low0.23 - 2.19
Open / Close0.32 / 0.32
Float / Outstanding23.5M / 25.2M
Vol / Avg.245.9K / 129.6K
Mkt Cap8M
P/E-
50d Avg. Price0.59
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float23.5M
Benzinga - 1 day ago
Benzinga - May 25, 2022, 4:40PM
Benzinga - May 24, 2022, 8:41AM
Benzinga - May 23, 2022, 8:33AM
Benzinga - May 18, 2022, 8:32AM
Benzinga - Apr 1, 2022, 1:25PM
Benzinga - Mar 31, 2022, 8:36AM
Benzinga - Jan 12, 2022, 8:37AM
Benzinga - Jan 5, 2022, 4:48PM
Benzinga - Jan 5, 2022, 3:04PM
Benzinga - Jan 4, 2022, 10:55AM
Benzinga - Jan 4, 2022, 8:35AM
Benzinga - Nov 16, 2021, 8:35AM
Benzinga - Oct 6, 2021, 8:34AM
Benzinga - Oct 6, 2021, 8:34AM
Benzinga - Aug 17, 2021, 8:16AM
Benzinga - Aug 12, 2021, 8:58AM
Benzinga - Aug 12, 2021, 8:08AM
load more
Sector: Health Care.Industry: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.110-0.110 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Tenax Therapeutics Questions & Answers

Q
How do I buy Tenax Therapeutics (TENX) stock?
A

You can purchase shares of Tenax Therapeutics (NASDAQ: TENX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Tenax Therapeutics's (TENX) competitors?
Q
What is the target price for Tenax Therapeutics (TENX) stock?
A

The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by HC Wainwright & Co. on Tuesday, December 29, 2020. The analyst firm set a price target for 5.00 expecting TENX to rise to within 12 months (a possible 1471.34% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Tenax Therapeutics (TENX)?
A

The stock price for Tenax Therapeutics (NASDAQ: TENX) is $0.3182 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Tenax Therapeutics (TENX) pay a dividend?
A

There are no upcoming dividends for Tenax Therapeutics.

Q
When is Tenax Therapeutics (NASDAQ:TENX) reporting earnings?
A

Tenax Therapeutics’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Tenax Therapeutics (TENX) going to split?
A

There is no upcoming split for Tenax Therapeutics.

Q
What sector and industry does Tenax Therapeutics (TENX) operate in?
A

Tenax Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.